21641049|t|A mimotope peptide of Abeta42 fibril-specific antibodies with Abeta42 fibrillation inhibitory activity induces anti-Abeta42 conformer antibody response by a displayed form on an M13 phage in mice.
21641049|a|In Alzheimer's disease (AD), amyloid-beta (Abeta) peptides accumulate in the brain in different forms, including fibrils and oligomers. Recently, we established three distinct conformation-dependent human single-chain Fv (scFv) antibodies, including B6 scFv, which bound to Abeta42 fibril but not to soluble-form Abeta, inhibiting Abeta42 fibril formation. In this study, we determined the mimotopes of these antibodies and found a common mimotope sequence, B6-C15, using the Ph.D.-C7C phage library. The B6-C15 showed weak homology to the C-terminus of Abeta42 containing GXXXG dimerization motifs. We synthesized the peptide of B6-C15 fused with biotinylated TAT at the N-terminus (TAT-B6-C15) and characterized its biochemical features on an Abeta42-fibrillation reaction in vitro. We demonstrated that, first, TAT-B6-C15 inhibited Abeta42 fibril formation; secondly, TAT-B6-C15 bound to prefibril Abeta42 oligomers but not to monomers, trimers, tetramers, fibrils, or ultrasonicated fragments; thirdly, TAT-B6-C15 inhibited Abeta42-induced cytotoxicity against human SH-SY5Y neuroblastoma cells; and, fourthly, when mice were administered B6-C15-phages dissolved in phosphate-buffered saline, the anti-Abeta42 conformer IgG antibody response was induced. These results suggested that the B6-C15 peptide might provide unique opportunities to analyze the Abeta42 fibrillation pathway and develop a vaccine vehicle for Alzheimer's disease.
21641049	22	29	Abeta42	Gene	351
21641049	62	69	Abeta42	Gene	351
21641049	116	123	Abeta42	Gene	351
21641049	191	195	mice	Species	10090
21641049	200	219	Alzheimer's disease	Disease	MESH:D000544
21641049	221	223	AD	Disease	MESH:D000544
21641049	226	238	amyloid-beta	Gene	351
21641049	240	245	Abeta	Gene	351
21641049	396	401	human	Species	9606
21641049	471	478	Abeta42	Gene	351
21641049	510	515	Abeta	Gene	351
21641049	528	535	Abeta42	Gene	351
21641049	679	682	C7C	DNAMutation	tmVar:c|SUB|C|7|C;HGVS:c.7C>C;VariantGroup:0;CorrespondingGene:351;CorrespondingSpecies:9606
21641049	751	758	Abeta42	Gene	351
21641049	858	861	TAT	Gene	6898
21641049	881	884	TAT	Gene	6898
21641049	942	949	Abeta42	Gene	351
21641049	1011	1014	TAT	Gene	6898
21641049	1032	1039	Abeta42	Gene	351
21641049	1068	1071	TAT	Gene	6898
21641049	1098	1105	Abeta42	Gene	351
21641049	1204	1207	TAT	Gene	6898
21641049	1225	1232	Abeta42	Gene	351
21641049	1241	1253	cytotoxicity	Disease	MESH:D064420
21641049	1262	1267	human	Species	9606
21641049	1268	1289	SH-SY5Y neuroblastoma	CellLine	CVCL:0019
21641049	1317	1321	mice	Species	10090
21641049	1367	1376	phosphate	Chemical	MESH:D010710
21641049	1403	1410	Abeta42	Gene	351
21641049	1554	1561	Abeta42	Gene	351
21641049	1617	1636	Alzheimer's disease	Disease	MESH:D000544
21641049	Negative_Correlation	MESH:D064420	6898
21641049	Association	MESH:D000544	351
21641049	Negative_Correlation	351	6898
21641049	Association	MESH:D064420	351

